598 related articles for article (PubMed ID: 1690599)
1. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
Messing EM
Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
[TBL] [Abstract][Full Text] [Related]
2. Expression of the epidermal growth factor receptor family in normal and malignant urothelium.
Røtterud R; Nesland JM; Berner A; Fosså SD
BJU Int; 2005 Jun; 95(9):1344-50. PubMed ID: 15892828
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
[TBL] [Abstract][Full Text] [Related]
4. Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells.
Theodorescu D; Cornil I; Sheehan C; Man MS; Kerbel RS
Cancer Res; 1991 Aug; 51(16):4486-91. PubMed ID: 1868471
[TBL] [Abstract][Full Text] [Related]
5. Normal and malignant human urothelium: in vitro effects of epidermal growth factor.
Messing EM; Reznikoff CA
Cancer Res; 1987 May; 47(9):2230-5. PubMed ID: 3494507
[TBL] [Abstract][Full Text] [Related]
6. Translational studies of glutathione in bladder cancer cell lines and human specimens.
Pendyala L; Velagapudi S; Toth K; Zdanowicz J; Glaves D; Slocum H; Perez R; Huben R; Creaven PJ; Raghavan D
Clin Cancer Res; 1997 May; 3(5):793-8. PubMed ID: 9815751
[TBL] [Abstract][Full Text] [Related]
7. A nuclear form of the heparin-binding epidermal growth factor-like growth factor precursor is a feature of aggressive transitional cell carcinoma.
Adam RM; Danciu T; McLellan DL; Borer JG; Lin J; Zurakowski D; Weinstein MH; Rajjayabun PH; Mellon JK; Freeman MR
Cancer Res; 2003 Jan; 63(2):484-90. PubMed ID: 12543806
[TBL] [Abstract][Full Text] [Related]
8. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
9. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
Lazzeri M; Vannucchi MG; Spinelli M; Bizzoco E; Beneforti P; Turini D; Faussone-Pellegrini MS
Eur Urol; 2005 Oct; 48(4):691-8. PubMed ID: 15992990
[TBL] [Abstract][Full Text] [Related]
10. P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification.
Kalantari MR; Ahmadnia H
Urol J; 2007; 4(4):230-3. PubMed ID: 18270948
[TBL] [Abstract][Full Text] [Related]
11. In vitro modulation of implantation and intraepithelial expansion of bladder tumor cells by epidermal growth factor.
Bindels EM; Vermey M; Rebel JM; Zwarthoff EC; Van Der Kwast TH
Exp Cell Res; 1997 Sep; 235(2):395-402. PubMed ID: 9299164
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma.
Gleave ME; Hsieh JT; Wu HC; Hong SJ; Zhau HE; Guthrie PD; Chung LW
Cancer Res; 1993 Nov; 53(21):5300-7. PubMed ID: 8221665
[TBL] [Abstract][Full Text] [Related]
13. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factors and their specific binding sites in normal urothelium and transitional cell carcinoma (TCC) of the human bladder.
Palcy S; Chopin DK; Caruelle D; Ravery V; Barritault D; Caruelle JP
Cell Mol Biol (Noisy-le-grand); 1995 Jun; 41(4):565-75. PubMed ID: 7549793
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
Moll R; Achtstätter T; Becht E; Balcarova-Ständer J; Ittensohn M; Franke WW
Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018
[TBL] [Abstract][Full Text] [Related]
16. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
Zhou JT; Cai ZM; Li NC; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor-responsive and -refractory carcinomas initiated with N-methyl-N-nitrosourea in rat urinary bladder.
Fujimoto K; Tanaka Y; Rademaker A; Oyasu R
Cancer Res; 1996 Jun; 56(11):2666-70. PubMed ID: 8653714
[TBL] [Abstract][Full Text] [Related]
18. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
[TBL] [Abstract][Full Text] [Related]
19. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
[TBL] [Abstract][Full Text] [Related]
20. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB
Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
